A5076194922- Hepatitis C virus research
- Hepatitis B Virus Studies
- HIV, Drug Use, Sexual Risk
- Liver Disease Diagnosis and Treatment
- COVID-19 epidemiological studies
- Emergency and Acute Care Studies
- Hormonal and reproductive studies
- HIV/AIDS drug development and treatment
- HIV-related health complications and treatments
- HIV/AIDS Research and Interventions
- SARS-CoV-2 and COVID-19 Research
- Pharmaceutical industry and healthcare
- COVID-19 Pandemic Impacts
- Social Media in Health Education
- Pharmacology and Obesity Treatment
- Interpreting and Communication in Healthcare
- Heart Failure Treatment and Management
- Cytomegalovirus and herpesvirus research
- LGBTQ Health, Identity, and Policy
- Hepatitis Viruses Studies and Epidemiology
- Maternal Mental Health During Pregnancy and Postpartum
- Healthcare Policy and Management
- Homelessness and Social Issues
- Mental Health Treatment and Access
- Health disparities and outcomes
University of Bristol
2024-2025
Burnet Institute
2022-2025
At Bristol
2024
St Vincent's Hospital Sydney
2023
Alexandra Hospital
2023
Deakin University
2023
Monash University
2023
The University of Melbourne
2023
Murdoch Children's Research Institute
2023
To ascertain the adverse health outcomes experienced by those using prescribed testosterone and non-prescribed anabolic-androgenic steroids presenting to general practitioner (GP) clinics.
Long-acting injectable buprenorphine (LAIB) reduces the frequency of contact with opioid agonist therapy (OAT) service providers. Limited data exist on OAT prescribing in Australia after introduction subsidised LAIB September 2019. This ecological study describes trends between 2015 and 2023 across a network primary care services Victoria, Australia. We utilised electronic medical records from 17 clinics Victoria that provide to people dependence describe patterns. described annual number...
A barrier to hepatitis C virus (HCV) cure is conventional testing. The aim of this study was evaluate the effect HCV antibody and RNA point-of-care testing (POCT) on rates, linkage care, treatment, acceptability in 3 priority settings Australia.
The PUSH! Audit was a cross-sectional study performed from May 2019 to 2021. With each audit submitted, general practitioners (GPs) were asked about the impact of their engagement with patients.In all, 144 responses collected, 81.6% audits showing change in behaviour. changes noted better monitoring (71.3%), treatment adverse effects (64.4%), modified use (44.4%) and stopped (12.2%).This asking GPs outcomes patients using non-prescribed PIEDs has shown significant There been no previous work...
Abstract Objective s Improved life expectancy has led to an ageing population of people living with HIV in most countries. Research on among predominantly focused physical and health‐related quality rather than multidimensional life. We measured older Australia identified opportunities guide the development implementation appropriate interventions. Methods In a national health wellbeing survey Australian HIV, participants aged ≥50 years completed additional questions relevant ageing. Quality...
Abstract Introduction Australia has experienced sustained reductions in hepatitis C testing and treatment may miss its 2030 elimination targets. Addressing gaps community-based prescribing priority settings that did not have, or prioritise, care pathways is critical. Methods The Tasmanian Eliminate Hepatitis Outreach Project delivered a nurse-led outreach model of servicing populations the community through Statewide Sexual Health Service, supported by Eliminating partnership. Settings...
Prescribing testosterone for gender affirming hormone therapy (GAHT) has been increasing in Australia with much of this practice done by general practitioners (GPs) and there are current AusPATH guidelines on how can be appropriately. There limited data collected from GPs about well these patients monitored the adverse effects (AEs) that experienced population patients.
The International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC) is a multinational consortium of longitudinal cohorts people with who are at risk hepatitis virus (HCV) infection or infected HCV.InCHEHC has been specifically designed to assess progress towards HCV elimination as public health threat among HIV.• first data merge includes 104 740 participants from 11 Australia (n ¼ 22 033), Canada 2070), France 18 387), Netherlands 24 785), Spain 16 725) and Switzerland 20...
Background: Understanding the effectiveness of novel models care in community-based settings is critical to achieving hepatitis C elimination. We conducted an evaluation a model with financial incentives that aimed improve engagement across cascade at sexual health service Cairns, Australia. Methods: Between March 2020 and May 2021, were embedded into established person-centred Cairns Sexual Health Service. Clients Service who self-reported experiences injecting drugs offered AUD 20 cash...
Background: Point-of-care hepatitis C virus (HCV) testing streamlines and treatment pathways. In this study, we established an HCV model of care in a homelessness service by offering antibody RNA point-of-care testing. Methods: A nurse peer-led with peer support were implemented between November 2021 April 2022 at Adelaide, Australia. All clients the eligible to participate. Clients offered initial test, positive immediately who tested linked viral for treatment. Results: total 230 received...
Purpose Access to professional interpreter services is a critical facilitator of positive health-care experiences when professionals and women accessing maternity care are not proficient in shared language. Understanding demand essential for the provision services. This study aims characterise requirements among from nonrefugee refugee non-English-speaking migrant backgrounds Australian hospitals. Design/methodology/approach analysed administrative data four public hospitals Victoria,...